Haag-Streit USA and Marco Lombart Unveil Octopus 910 at AAO 2026
Haag-Streit USA and Marco Lombart Launch Octopus 910 at AAO 2026
Haag-Streit USA, a prominent player in the ophthalmic device market, partnered with Marco Lombart, an Advancing Eyecare company, to introduce the Octopus 910 to U.S. audiences at the American Academy of Ophthalmology (AAO) 2026. Taking place from October 10 to 12, 2026, at the Ernest N. Morial Convention Center in New Orleans, this event marks a significant milestone in modern visual field testing.
The Octopus 910 is designed to elevate glaucoma management, offering a vast toolbox of features for assessing visual fields comprehensively. Some standout attributes include Cluster Analysis, Stimulus V testing, and Polar Analysis, which cater to various stages of the disease. Eye care professionals can now integrate Hyberopia Visual Field Assessment results directly into the Octopus platform, enabling seamless monitoring of patient progression.
Smart Automation Enhances Efficiency
Aimed at optimizing the testing process, the Octopus 910 integrates several intelligent automation features that not only improve patient comfort but also enhance the reliability of results. With a motorized trial lens holder and automated patient positioning, this device minimizes human error while streamlining the patient experience. Additionally, a simplified chin and forehead rest ensures ergonomic comfort, while the built-in occluder assists in creating a controlled testing environment.
The device’s smart guidance capabilities are tailored for both patients and examiners. Using voice instructions, status lights, and active eye tracking, the Octopus 910 effectively reduces setup errors and improves the consistency of test outcomes. This automation allows practitioners to focus on patient care rather than manual adjustments, ultimately yielding more reproducible results.
Responses from Haag-Streit and Marco Lombart
Andrew Jones, Vice President of Sales and Marketing at Haag-Streit USA, expressed enthusiasm about the launch: "We are eager to present the Octopus 910 to U.S. healthcare professionals. It represents a vital addition to our product lineup, merging comprehensive glaucoma management with intuitive support that enables clinicians to enhance their testing efficiency."
Jocelyn Hamilton, President of U.S. Sales at Advancing Eyecare, echoed this sentiment: "The Octopus 910 combines advanced technology with smart automation, making visual field testing more efficient and comfortable. We are equipped to assist practitioners in confidently incorporating this innovative tool into their services."
Nationwide Launch and Training
With Marco Lombart acting as the exclusive U.S. distributor for Haag-Streit’s Octopus perimetry line, eye care professionals nationwide can anticipate comprehensive training and support throughout the integration process. After its initial U.S. introduction at AAO 2026, the Octopus 910 is set for a global launch in January 2027, expanding its reach and impact.
About Haag-Streit USA
Located in Mason, OH, Haag-Streit USA is a subsidiary of the Haag-Streit Group, providing state-of-the-art diagnostic and surgical equipment to the eye care market. Their extensive offering includes slit lamps, biometers, and perimeters, thus playing a crucial role in advancing ophthalmic care.
About Marco Lombart and Advancing Eyecare
Marco Lombart, an Advancing Eyecare company, specializes in ophthalmic instruments, ensuring that healthcare providers have access to precision technology and ongoing support. Advancing Eyecare comprises various leading brands, all dedicated to delivering top-tier products and service solutions within the eyewear landscape.
For more information about the Octopus 910, its features, and to view its launch video, please visit the Haag-Streit and Marco Lombart websites.